Suppr超能文献

钙敏感受体拮抗剂抑制钙敏感受体促进帕金森病模型小鼠的胃肠动力。

Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson's disease mouse model.

机构信息

Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.

Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

出版信息

Biomed Pharmacother. 2024 May;174:116518. doi: 10.1016/j.biopha.2024.116518. Epub 2024 Apr 1.

Abstract

BACKGROUND

The Calcium-sensing receptor (CaSR) participates in the regulation of gastrointestinal (GI) motility under normal conditions and might be involved in the regulation of GI dysmotility in patients with Parkinson's disease (PD).

METHODS

CaSR antagonist-NPS-2143 was applied in in vivo and ex vivo experiments to study the effect and underlying mechanisms of CaSR inhibition on GI dysmotility in the MPTP-induced PD mouse model.

FINDINGS

Oral intake of NPS-2143 promoted GI motility in PD mice as shown by the increased gastric emptying rate and shortened whole gut transit time together with improved weight and water content in the feces of PD mice, and the lack of influence on normal mice. Meanwhile, the number of cholinergic neurons, the proportion of serotonergic neurons, as well as the levels of acetylcholine and serotonin increased, but the numbers of nitrergic and tyrosine hydroxylase immunoreactive neurons, and the levels of nitric oxide synthase and dopamine decreased in the myenteric plexus in the gastric antrum and colon of PD mice in response to NPS-2143 treatment. Furthermore, the numbers of c-fos positive neurons in the nucleus tractus solitarius (NTS) and cholinergic neurons in the dorsal motor nucleus of the vagus (DMV) increased in NPS-2143 treated PD mice, suggesting the involvement of both the enteric (ENS) and central (CNS) nervous systems. However, ex vivo results showed that NPS-2143 directly inhibited the contractility of antral and colonic strips in PD mice via a non-ENS mediated mechanism. Further studies revealed that NPS-2143 directly inhibited the voltage gated Ca channels, which might, at least in part, explain its direct inhibitory effects on the GI muscle strips.

INTERPRETATION

CaSR inhibition by its antagonist ameliorated GI dysmotility in PD mice via coordinated neuronal regulation by both ENS and CNS in vivo, although the direct effects of CaSR inhibition on GI muscle strips were suppressive.

摘要

背景

钙敏感受体(CaSR)在正常情况下参与胃肠道(GI)运动的调节,并且可能参与帕金森病(PD)患者的 GI 动力障碍的调节。

方法

应用 CaSR 拮抗剂 NPS-2143 进行体内和离体实验,研究 CaSR 抑制对 MPTP 诱导的 PD 小鼠模型中 GI 动力障碍的作用及潜在机制。

发现

NPS-2143 的口服摄入促进了 PD 小鼠的 GI 运动,表现为胃排空率增加,整个肠道通过时间缩短,PD 小鼠的粪便重量和水分增加,而对正常小鼠没有影响。同时,NPS-2143 处理后,PD 小鼠胃窦和结肠的肌间神经丛中胆碱能神经元的数量、5-羟色胺能神经元的比例、乙酰胆碱和 5-羟色胺的水平增加,而氮能和酪氨酸羟化酶免疫反应性神经元的数量、一氧化氮合酶和多巴胺的水平降低。此外,NPS-2143 治疗的 PD 小鼠中,孤束核(NTS)中的 c-fos 阳性神经元和迷走神经背核(DMV)中的胆碱能神经元的数量增加,提示 ENS 和中枢神经系统(CNS)均参与其中。然而,离体结果表明,NPS-2143 通过非 ENS 介导的机制直接抑制 PD 小鼠胃窦和结肠段的收缩性。进一步的研究表明,NPS-2143 直接抑制电压门控钙通道,这至少部分解释了其对 GI 肌条的直接抑制作用。

结论

CaSR 拮抗剂通过体内 ENS 和 CNS 的协调神经元调节,改善 PD 小鼠的 GI 动力障碍,尽管 CaSR 抑制对 GI 肌条的直接作用是抑制性的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验